These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2907487)

  • 41. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
    Sammut S; Bray KE; West AR
    Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs.
    Gueudet C; Santucci V; Soubrié P; Le Fur G
    Synapse; 1999 Jul; 33(1):71-9. PubMed ID: 10380852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
    Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.
    Freeman AS; Bunney BS
    Brain Res; 1987 Mar; 405(1):46-55. PubMed ID: 3032350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.
    White FJ; Wang RY
    Science; 1983 Sep; 221(4615):1054-7. PubMed ID: 6136093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective sigma receptor agonist and antagonist affect dopamine neuronal activity.
    Steinfels GF; Tam SW
    Eur J Pharmacol; 1989 Apr; 163(1):167-70. PubMed ID: 2568265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
    Bennett S; Gronier B
    Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.
    Rasmussen K; Stockton ME; Czachura JF
    Eur J Pharmacol; 1991 Nov; 205(1):113-6. PubMed ID: 1811993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
    Zdilar D; Lacković Z
    Eur J Pharmacol; 1989 May; 164(1):159-62. PubMed ID: 2568936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.
    Olijslagers JE; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Neuropharmacology; 2004 Mar; 46(4):504-10. PubMed ID: 14975674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.
    Erhardt S; Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1999; 106(5-6):383-94. PubMed ID: 10443545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of prenatal cocaine exposure on spontaneously active midbrain dopamine neurons in adult male offspring: an electrophysiological study.
    Minabe Y; Ashby CR; Heyser C; Spear LP; Wang RY
    Brain Res; 1992 Jul; 586(1):152-6. PubMed ID: 1511345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.